Many patients with localized prostate cancer don’t understand the differences between their treatment options, a new study suggests. READ MORE

Research in Review

Patients choosing surveillance over aggressive treatment for prostate cancer are not being monitored as closely as they should be, according to a new study published by a team of University of California, Los Angeles (UCLA) researchers in the journal Cancer.